Hostname: page-component-7b7567c8c-9cwtv Total loading time: 0 Render date: 2026-11-19T11:22:04.907Z Has data issue: false hasContentIssue false

NIH Licensing Would Benefit from Free-Market Provisions

Published online by Cambridge University Press:  04 March 2024

Rights & Permissions [Opens in a new window]

Abstract

Government encouragement of free markets is a highly effective means of fostering pharmaceutical innovation; the NIH, by including “free-market provisions” in its licensing agreements that discourage anti-competitive and research-impeding behavior, can do a great deal to support this goal even without legislative overhaul.